Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Bioorg Med Chem Lett ; 20(1): 266-71, 2010 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-19914063

RESUMEN

Based on our original pyrazine hit, CP-0809101, novel conformationally-restricted 5HT2c receptor agonists with 2-piperazin-azaindane scaffold were designed. Synthesis and structure-activity relationship (SAR) studies are described with emphasis on optimization of the selectivity against 5HT2a and 5HT2b receptors with excellent 2c potency. Orally-active and selective compounds were identified with dose-responsive in vivo efficacy in our pre-clinical food intake model.


Asunto(s)
Fármacos Antiobesidad/síntesis química , Compuestos Aza/síntesis química , Agonistas del Receptor de Serotonina 5-HT2 , Agonistas de Receptores de Serotonina/síntesis química , Administración Oral , Animales , Fármacos Antiobesidad/química , Fármacos Antiobesidad/farmacología , Compuestos Aza/química , Compuestos Aza/farmacología , Perros , Diseño de Fármacos , Haplorrinos , Humanos , Obesidad/tratamiento farmacológico , Ratas , Receptor de Serotonina 5-HT2C/metabolismo , Agonistas de Receptores de Serotonina/química , Agonistas de Receptores de Serotonina/farmacología
3.
J Biomol Screen ; 14(4): 360-70, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19403919

RESUMEN

Novel fluorescent derivatives of serotonin have been synthesized and used as tracers for the development of a 5-HT2C fluorescence polarization assay. Serotonin analogs that feature a fluorescent probe attached through an ether linkage at the tryptamine 5-position have high affinity for the 5-HT2C receptor, and affinity is dependent on both linker length and pendent dye. These variables have been optimized to generate Cy3B derivative 5a, which has 10-fold higher 5-HT2C affinity relative to serotonin (Kd=0.23 nM). In receptor activation experiments, 5a acts as a full agonist of 5-HT2C. Upon binding to 5-HT2C cell membranes, 5a shows a robust increase in fluorescence polarization (FP) signal. In an FP binding assay using 5a as a tracer ligand, Ki values for known 5-HT2C agonists and antagonists showed excellent agreement with Ki values from radioligand binding (r2=0.93). The FP ligand assay is suitable for high-throughput drug screening applications with respect to speed of analysis, displaceable signal, precision, and sensitivity to various reagents. A 384-well-based high-throughput assay that is rapid, economical, and predictive of test compounds' ability to bind to the 5-HT2C receptor has been compiled and validated.


Asunto(s)
Diseño de Fármacos , Colorantes Fluorescentes/metabolismo , Receptor de Serotonina 5-HT2C/análisis , Serotonina/análogos & derivados , Coloración y Etiquetado , Animales , Bioensayo , Polarización de Fluorescencia , Humanos , Cinética , Ratones , Células 3T3 NIH , Receptor de Serotonina 5-HT2C/metabolismo , Estándares de Referencia , Reproducibilidad de los Resultados , Relación Estructura-Actividad
4.
J Health Popul Nutr ; 27(4): 545-62, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19761088

RESUMEN

The private sector is often seen as a driver of exclusionary processes rather than a partner in improving the health and welfare of socially-excluded populations. However, private-sector initiatives and partnerships- collectively labelled corporate social responsibility (CSR) initiatives-may be able to positively impact social status, earning potential, and access to services and resources for socially-excluded populations. This paper presents case studies of CSR projects in Bangladesh that are designed to reduce social exclusion among marginalized populations and explores whether CSR initiatives can increase economic and social capabilities to reduce exclusion. The examples provide snapshots of projects that (a) increase job-skills and employment opportunities for women, disabled women, and rehabilitated drug-users and (b) provide healthcare services to female workers and their communities. The CSR case studies cover a limited number of people but characteristics and practices replicable and scaleable across different industries, countries, and populations are identified. Common success factors from the case studies form the basis for recommendations to design and implement more CSR initiatives targeting socially-excluded groups. The analysis found that CSR has potential for positive and lasting impact on developing countries, especifically on socially-excluded populations. However, there is a need for additional monitoring and critical evaluation.


Asunto(s)
Servicios de Salud Comunitaria/métodos , Relaciones Comunidad-Institución , Promoción de la Salud/métodos , Sector Privado , Responsabilidad Social , Bangladesh , Política de Salud , Humanos , Estudios de Casos Organizacionales , Pobreza , Servicios de Salud Rural , Población Rural , Lugar de Trabajo
5.
J Health Popul Nutr ; 27(4): 563-73, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19761089

RESUMEN

Health services and modem medicines are out of reach for over one billion people globally. Micro-insurance for health is one method to address unmet health needs. This case study used a social exclusion perspective to assess the health and poverty impact of micro-insurance for health in Bangladesh and contrasts this with several micro-insurance systems for health offered in India. Micro-insurance for health in Bangladesh targeted towards the poor and the ultra-poor provides basic healthcare at an affordable rate whereas the Indian micro-insurance schemes for health have been implemented across larger populations and include high-cost and low-frequency events. Results of analysis of the existing literature showed that micro-insurance for health as currently offered in Bangladesh increased access to, and use of, basic health services among excluded populations but did not reduce the likelihood that essential health-related costs would be a catastrophic expense for a marginalized household.


Asunto(s)
Servicios de Salud Comunitaria/economía , Gastos en Salud , Accesibilidad a los Servicios de Salud/economía , Seguro de Salud/economía , Pobreza , Bangladesh , Costos de la Atención en Salud , Disparidades en Atención de Salud , Humanos , India , Estudios de Casos Organizacionales , Gestión de Riesgos/economía , Gestión de Riesgos/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA